203 related articles for article (PubMed ID: 17917937)
1. Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years?
Morsy H; Kamp S; Jemec GB
J Dermatolog Treat; 2007; 18(5):261-7. PubMed ID: 17917937
[TBL] [Abstract][Full Text] [Related]
2. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.
Le Cleach L; Chassany O; Levy A; Wolkenstein P; Chosidow O
Dermatology; 2008; 216(1):46-55. PubMed ID: 18032899
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.
Shikiar R; Bresnahan BW; Stone SP; Thompson C; Koo J; Revicki DA
Health Qual Life Outcomes; 2003 Oct; 1():53. PubMed ID: 14613569
[TBL] [Abstract][Full Text] [Related]
4. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006.
Naldi L; Svensson A; Zenoni D; Diepgen T; Elsner P; Grob JJ; Coenraads PJ; Bouwes Bavinck JN; Maccagni A; Linder D; Williams H;
Br J Dermatol; 2010 Feb; 162(2):384-9. PubMed ID: 19785620
[TBL] [Abstract][Full Text] [Related]
5. [What are the objectives of moderate to severe psoriasis treatment?].
Ortonne JP
Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S281-4. PubMed ID: 18721665
[TBL] [Abstract][Full Text] [Related]
6. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.
Reich K; Griffiths CE
Arch Dermatol Res; 2008 Nov; 300(10):537-44. PubMed ID: 18784934
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis assessment tools in clinical trials.
Feldman SR; Krueger GG
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii65-8; discussion ii69-73. PubMed ID: 15708941
[TBL] [Abstract][Full Text] [Related]
8. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies.
Naldi L
Clin Dermatol; 2010; 28(1):67-72. PubMed ID: 20082954
[TBL] [Abstract][Full Text] [Related]
9. Methods of outcomes measurement in nail psoriasis.
Augustin M; Ogilvie A
Dermatology; 2010; 221 Suppl 1():23-8. PubMed ID: 20733312
[TBL] [Abstract][Full Text] [Related]
10. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
11. Treatment goals in psoriasis.
Reich K; Mrowietz U
J Dtsch Dermatol Ges; 2007 Jul; 5(7):566-74. PubMed ID: 17610606
[TBL] [Abstract][Full Text] [Related]
12. A review of health outcomes in patients with psoriasis.
Li K; Armstrong AW
Dermatol Clin; 2012 Jan; 30(1):61-72, viii. PubMed ID: 22117868
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis therapy in real life: the need for registries.
Schmitt-Egenolf M
Dermatology; 2006; 213(4):327-30. PubMed ID: 17135739
[TBL] [Abstract][Full Text] [Related]
14. Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review.
Garduno J; Bhosle MJ; Balkrishnan R; Feldman SR
J Dermatolog Treat; 2007; 18(4):223-42. PubMed ID: 17671883
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
16. Fecal incontinence: the quality of reported randomized, controlled trials in the last ten years.
Parés D; Norton C; Chelvanayagam S
Dis Colon Rectum; 2008 Jan; 51(1):88-95. PubMed ID: 18085335
[TBL] [Abstract][Full Text] [Related]
17. [What's new in dermatological therapy?].
Paul C
Ann Dermatol Venereol; 2007 Dec; 134 Suppl 1():8S64-75. PubMed ID: 18675142
[TBL] [Abstract][Full Text] [Related]
18. An updated survey for the 2007-2013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship.
Manalo IF; Gilbert KE; Wu JJ
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1945-50. PubMed ID: 25763768
[TBL] [Abstract][Full Text] [Related]
19. Review of therapy of psoriasis: the prebiologic armamentarium.
Aaronson DS; Lebwohl M
Dermatol Clin; 2004 Oct; 22(4):379-88, viii. PubMed ID: 15450334
[TBL] [Abstract][Full Text] [Related]
20. Assessment of disease progress in psoriasis.
Marks R; Barton SP; Shuttleworth D; Finlay AY
Arch Dermatol; 1989 Feb; 125(2):235-40. PubMed ID: 2643928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
